ARS Pharmaceuticals Inc
SPRY
M
|
$8.5
3.53%
3.18%
510K
|
Manufacturing
(0.0% 1d) (-6.9% 1m) (30.8% 1y) (0.0% 2d) (3.5% 3d) (0.4% 7d) (29.34% volume)
Earnings Calendar: 2023-11-14
Market Cap: $ 820,263,209
https://silverbacktx.com
Sec Filling | Patents | 54 employees
Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.
msa
add to watch list Paper trade email alert is off
Press-releases
ARS Pharmaceuticals Submits Response to FDA Complete Response Letter for neffy® (Epinephrine Nasal Spray)
Published: 2024-04-03 (Crawled : 13:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: 0.32%
H: 4.03%
C: 0.97%
neffy fda pharmaceuticals response
ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-21 (Crawled : 20:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: 0.0%
H: 1.11%
C: -3.89%
business year update pharmaceuticals financial results
ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day
Published: 2024-03-07 (Crawled : 21:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: 0.78%
H: 0.89%
C: -3.66%
neffy day pharmaceuticals commercial
ARS Pharmaceuticals to Participate in the Leerink Partners Global Biopharma Conference 2024
Published: 2024-03-06 (Crawled : 14:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: 1.35%
H: 0.44%
C: -0.89%
conference biopharma pharmaceuticals global
ARS Pharmaceuticals announces neffy® meets primary endpoints and shows rapid symptom control in Phase 2 urticaria clinical study
Published: 2024-02-26 (Crawled : 14:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: 2.63%
H: 6.77%
C: 2.1%
neffy urticaria rapid control pharmaceuticals study
ARS Pharmaceuticals to Host Virtual neffy® Investor Day on March 7, 2024
Published: 2024-02-22 (Crawled : 14:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: 0.54%
H: 3.87%
C: 1.33%
neffy day pharmaceuticals
ARS Pharma Announces Favorable Topline Results from Repeat Dosing Study of neffy® (Epinephrine Nasal Spray) Under Nasal Allergen Challenge Conditions, Readies Data for Response to FDA’s Complete Response Letter
Published: 2024-02-20 (Crawled : 14:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: -3.77%
H: 14.35%
C: 8.99%
neffy pharma favorable topline response results study
ARS Pharmaceuticals to Present Positive Clinical Efficacy Data for neffy® (epinephrine nasal spray) at 2024 AAAAI Annual Meeting
Published: 2024-02-05 (Crawled : 14:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: 0.16%
H: 2.2%
C: 0.16%
neffy positive pharmaceuticals meeting
ARS Pharmaceuticals Announces Presentation of Clinical Data Supporting neffy® (epinephrine nasal spray) for the Treatment of Allergic Reactions (Type I) including Anaphylaxis
Published: 2023-11-09 (Crawled : 16:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: 0.56%
H: 1.11%
C: -4.72%
neffy presentation treatment pharmaceuticals
ARS Pharmaceuticals Announces Scheduling of a Type A Meeting with the U.S. FDA for neffy® (epinephrine nasal spray)
Published: 2023-10-06 (Crawled : 13:00) - globenewswire.com
SPRY M | $8.5 3.53% 3.18% 510K
|
Manufacturing
|
| O: -0.75%
H: 10.35%
C: 7.83%
neffy fda pharmaceuticals meeting
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.98 1.91% 0.0% 140K
|
|
00:30
CTRN P 29000 | $22.23 0.05% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.7 1.09% 1.35% 74K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.685 -0.68% 39.71% 6.6K
|
Utilities
|
18:30
CMTV P 700 | $16.59 5.4% 17.43% 1K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.66% 2.5M
|
Finance
|
17:30
RMCF | $3.54 -0.84% 0.28% 2.8K
|
Consumer Non-Durables
|
20:10